Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Adaptin Bio, Inc. (APTN) AI Forecast

Our AI analyzed Adaptin Bio, Inc.. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$APTN Neutral Signal Full forecast available
Sign Up Free

Adaptin Bio, Inc. (APTN) Stock Forecast Aug. 18, 2026

Adaptin Bio, Inc. (APTN) AI Stock Price Forecast & Investment Analysis

Adaptin Bio, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Adaptin Bio, Inc. (APTN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Adaptin Bio, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on August 18, 2026, 11:42 p.m. (UTC)

Adaptin Bio, Inc. Investment Summary

When evaluating whether Adaptin Bio, Inc. (APTN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Adaptin Bio, Inc. (APTN) operates within the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. . With a market capitalization of $57 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Adaptin Bio, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Adaptin Bio, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Adaptin Bio, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Adaptin Bio, Inc.

Sign Up Free
Corporate Identity

Adaptin Bio, Inc. (Stock Symbol: APTN) is a prominent company operating within the Life Sciences sector, with a specific focus on the Biological Products, (No Diagnostic Substances) industry. The company's shares are publicly traded on the OTC exchange.

Leadership & Workforce

Detailed information about Adaptin Bio, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Adaptin Bio, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Adaptin Bio, Inc....

Unlock Full Company Profile

Get complete details about Adaptin Bio, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Adaptin Bio, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Adaptin Bio, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Adaptin Bio, Inc....

Unlock Financial Analysis

Get complete financial metrics for Adaptin Bio, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Adaptin Bio, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Adaptin Bio, Inc. strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Adaptin Bio, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Current ratio of 0.37 reflects potential liquidity concerns with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, this warrants understanding of the specific circumstances.

Adaptin Bio, Inc. (APTN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Adaptin Bio, Inc. stock analysis.

Deep dive into Adaptin Bio, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Adaptin Bio, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Adaptin Bio, Inc.:

Market Cap $57M
EPS $-0.04
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Adaptin Bio, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Adaptin Bio, Inc.: An ROE of 12.4% shows good shareholder value creation.

ROE 12.4%
ROA -21.0%
ROIC 10.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Adaptin Bio, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Adaptin Bio, Inc.: A current ratio of 0.37 suggests potential liquidity concerns.

Current Ratio 0.37x
D/E Ratio -1.59x
Financial Leverage -0.59x
Interest Coverage -436.1x
Working Capital -$2M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Adaptin Bio, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Adaptin Bio, Inc.:

Operating Cash Flow -$90K
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Adaptin Bio, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Adaptin Bio, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Adaptin Bio, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Adaptin Bio, Inc.:

Income Statement
Balance Sheet Highlights (% Of Assets)
Total Current Assets 1%
Cash & Short-term Investments 1%
Total Liabilities 3%
Short-term Debt 1%
Dividend & Shareholder Information
Shares Outstanding 9M
Growth Metrics (YoY)
EPS Growth -0.6%

Latest Adaptin Bio, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Adaptin Bio, Inc. (APTN) stock price and investment outlook.

📰 Loading...

Where APTN sits on the market map

Explore the map →

Adaptin Bio, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Adaptin Bio, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABOS ██% $198M x 3.5x
ABPO ██% $1M x x
ACOG ██% $187M x 3.5x
ADAPY ██% $8M x x
ADMA ██% $2.15B 12.7x 5.3x
ADPT ██% $3.91B x 27.3x
AGEN ██% $305M 3.3x x
AGTX ██% $800K x x
AIM ██% $6M x 0.8x
ALEC ██% $247M x x
ALGS ██% $42M x 1.3x
ALLO ██% $718M x 1.7x
ALVO ██% $1.23B x x
AMGN ██% $226.72B 25.9x 19.4x
APGE ██% $10.14B x x
APTN ██% $57M x x
APTOF ██% $4M x x
ARGX ██% $61.45B x x
ARMP ██% $166M x x
ARTV ██% $571M x 1.6x
ATRA ██% $79M x x
ATYR ██% $51M x 1.0x
AURA ██% $844M x 2.7x
AUTL ██% $607M x 8.1x
AVXL ██% $297M x 2.3x
BCAB ██% $5M x x
BCDA ██% $15M x 5.4x
BCLI ██% $16M x x
BCRX ██% $2.45B x x
BDTX ██% $118M x 1.2x
BEAM ██% $2.74B x 2.6x
BIIB ██% $31.29B 22.8x 1.7x
BKHA ██% $49M 96.2x x
BNTX ██% $23.30B x x
CABA ██% $493M x 2.3x
CADL ██% $917M x 7.3x
CCCC ██% $514M x 2.1x
CELZ ██% $7M x 0.8x
CERO ██% $480K x x
CGEM ██% $1.31B x 4.1x
CGEN ██% $222M 3.1x 2.2x
CGON ██% $6.81B x 6.6x
CGTX ██% $94M x 2.9x
CHRS ██% $178M x 2.9x
CLDI ██% $3M x 1.1x
CLLS ██% $313M x x
CMPX ██% $416M x 2.5x
CPMV ██% $440K x x
CRDF ██% $71M x 2.7x
CRDL ██% $216M x x
CRIS ██% $4M x 0.9x
CRSP ██% $5.25B x 3.0x
CSBR ██% $70M x 17.7x
CVM ██% $27M x 2.5x
DBVT ██% $908M x 5.7x
DNA ██% $441M x 1.1x
DNLI ██% $3.89B x 4.7x
DTIL ██% $209M x 4.6x
DYAI ██% $28M x x
EDIT ██% $436M x 4.1x
EIKN ██% $567M x 1.2x
ELUT ██% $43M 0.8x 2.7x
ENGN ██% $114M x 0.5x
ENTX ██% $143M x 19.7x
ENZN ██% $67M x 0.4x
ESLA ██% $33M x x
EVAX ██% $26M x x
EXEL ██% $13.02B 15.1x 7.1x
EXOZ ██% $58M x 15.9x
FATE ██% $306M x 2.0x
FDMT ██% $803M x 2.0x
FENC ██% $414M x 9.8x
GILD ██% $171.70B x 14.5x
GLUE ██% $1.32B x 2.7x
GNTA ██% $63M x 5.0x
GPLB ██% $180K x x
GRML ██% $31M x 0.5x
HALO ██% $11.25B 27.2x 78.4x
HUMA ██% $168M x 5.4x
IBRX ██% $7.97B x x
IKT ██% $318M x 2.1x
IMA ██% $66M x 0.5x
IMCR ██% $1.76B x 4.2x
IMTX ██% $1.27B x x
IMVT ██% $8.63B x 11.7x
INAB ██% $11M x 0.6x
INKT ██% $60M x x
INMB ██% $60M x 3.0x
INTS ██% $13M x 1.4x
IOVA ██% $3.16B x 4.3x
IPSC ██% $349M x 1.5x
IVVD ██% $213M x 1.2x
JATT ██% $100M x 0.5x
JSPR ██% $26M x 18.6x
KLRS ██% $97M x 1.7x
KOD ██% $2.60B x 42.5x
KRYS ██% $9.83B 40.7x 7.2x
KYMR ██% $9.72B x 6.4x
KYTX ██% $503M x 3.0x
LCTX ██% $271M x 4.4x
LENZ ██% $152M x 0.7x
LIFE ██% $3.38B x 69.3x
LIMN ██% $9M x 28.8x
LONA ██% $75M x 2.2x
LXEO ██% $381M x 1.6x
MAZE ██% $1.61B x 3.6x
MESO ██% $2.02B x x
MGTX ██% $1.27B 16.1x 5.9x
MGX ██% $46M x 0.4x
MOLN ██% $173M x x
MRNA ██% $25.26B x 3.7x
NBIX ██% $15.52B 22.0x 4.2x
NMRA ██% $296M x 6.7x
NVAX ██% $1.33B x x
OCGN ██% $458M x x
OTLK ██% $183M x x
PALI ██% $371M x 3.1x
PASG ██% $15M x 3.3x
PCVX ██% $8.41B x 3.1x
PHGE ██% $2M x x
PLUR ██% $17M x x
PLX ██% $178M 9.4x 2.5x
PMCB ██% $6M x 0.2x
PRME ██% $558M x 14.0x
PROK ██% $531M x x
PTHS ██% $102M x x
QGEN ██% $9.32B x 2.5x
QNCX ██% $35M x x
REPL ██% $1.26B x 11.9x
RGEN ██% $9.41B 226.6x 4.5x
RGNX ██% $711M x 9.9x
RLAY ██% $4.34B x 4.9x
RVMD ██% $43.64B x 16.8x
RXRX ██% $1.69B x 1.8x
SABS ██% $309M x 1.4x
SANA ██% $1.06B x 6.9x
SCLX ██% $48M x x
SCNI ██% $1M x 0.2x
SGMO ██% $29M x x
SGMOQ ██% $70M x x
SLDB ██% $941M x 2.5x
SLXN ██% $570K x 12.9x
SNTI ██% $14M x x
SRRK ██% $6.39B x 25.2x
SRZN ██% $282M x x
STRO ██% $373M x x
TARA ██% $232M x 1.4x
TARS ██% $3.07B x 8.9x
TCRX ██% $52M x 0.8x
TECH ██% $11.34B 103.5x 5.4x
TECX ██% $689M x 3.1x
TIL ██% $50M x 0.5x
TNYA ██% $154M x 2.2x
TSHA ██% $2.03B x 5.2x
TVGN ██% $29M x x
TWST ██% $7.45B x 16.7x
VACH ██% $541M 80.4x x
VALN ██% $651M x x
VCEL ██% $2.27B 93.6x 6.1x
VIR ██% $1.59B x 1.6x
VIVS ██% $4M x x
VOR ██% $1.25B 2.0x x
VXRT ██% $121M 3.2x 1.5x
VYGR ██% $199M x 1.3x
WINT ██% $40K x x
XFOR ██% $406M x 2.6x
ZEOX ██% $11M x 15.3x
ZIVO ██% $16M x x
ZURA ██% $555M x 2.8x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Adaptin Bio, Inc. Stock Forecast

How accurate are Adaptin Bio, Inc. stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for APTN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Adaptin Bio, Inc. stock price forecasts?

Our analysis considers Adaptin Bio, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Adaptin Bio, Inc. a good investment in 2026?

Based on our AI analysis, Adaptin Bio, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Adaptin Bio, Inc. forecasts updated?

Adaptin Bio, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Adaptin Bio, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...